MMP‐3 and ‐9 have higher plasma levels in patient subgroups than in the control group, the highest MMP‐3 and‐9 levels were obtained in the most severe presentation of CAD (STEMI) compared to NSTEMI and stable angina patients (P < 0.0001, for both). The gene discussed is MMP3; the disease is coronary artery disorder.